| May 5, 2026 | Other Grant / award ⓘ | Class A Common Stock | COSLER STEVEN D Director | +4,028 | $0.00 | $0 | 29,012 | low |
| May 5, 2026 | Other Grant / award ⓘ | Class A Common Stock | LEWIS RANDALL J Director | +4,028 | $0.00 | $0 | 15,071 | low |
| Mar 28, 2026 | Other Option exercise · Class B Common Stock → 1,413,939 Class A Common Stock | Class B Common Stock | Pharmacy Investors, LLC | -1,413,939 | — | — | 1,413,939 | low |
| Mar 28, 2026 | Other Option exercise | Class A Common Stock | Pharmacy Investors, LLC | +1,413,939 | — | — | 2,449,867 | low |
| Mar 28, 2026 | Other Option exercise · Class B Common Stock → 6,100,175 Class A Common Stock | Class B Common Stock | BINDLEY WILLIAM E Director | -6,100,175 | — | — | 6,100,175 | low |
| Mar 28, 2026 | Other Option exercise | Class A Common Stock | BINDLEY WILLIAM E Director | +6,100,175 | — | — | 10,569,491 | low |
| Mar 28, 2026 | Other Option exercise · Class B Common Stock → 471,057 Class A Common Stock | Class B Common Stock | Cardinal Equity Fund, L.P. | -471,057 | — | — | 471,057 | low |
| Mar 28, 2026 | Other Option exercise | Class A Common Stock | Cardinal Equity Fund, L.P. | +471,057 | — | — | 816,180 | low |
| Mar 28, 2026 | Other Option exercise · Class B Common Stock → 6,100,175 Class A Common Stock | Class B Common Stock | Salentine Thomas J Jr Director | -6,100,175 | — | — | 6,100,175 | low |
| Mar 28, 2026 | Other Option exercise | Class A Common Stock | Salentine Thomas J Jr Director | +6,100,175 | — | — | 10,569,491 | low |
| Mar 28, 2026 | Other Option exercise · Class B Common Stock → 608,570 Class A Common Stock | Class B Common Stock | Forbes Kendall Executive | -608,570 | — | — | 608,570 | low |
| Mar 28, 2026 | Other Option exercise | Class A Common Stock | Forbes Kendall Executive | +608,570 | — | — | 1,061,826 | low |
| Mar 28, 2026 | Other Option exercise · Class B Common Stock → 641,869 Class A Common Stock | Class B Common Stock | Morris David K Executive | -641,869 | — | — | 641,870 | low |
| Mar 28, 2026 | Other Option exercise | Class A Common Stock | Morris David K Executive | +641,869 | — | — | 896,341 | low |
| Mar 28, 2026 | Other Option exercise · Class B Common Stock → 6,100,175 Class A Common Stock | Class B Common Stock | Bindley Capital Partners I, LLC 10% owner | -6,100,175 | — | — | 6,100,175 | low |
| Mar 28, 2026 | Other Option exercise | Class A Common Stock | Bindley Capital Partners I, LLC 10% owner | +6,100,175 | — | — | 10,569,491 | low |
| Mar 28, 2026 | Other Option exercise · Class B Common Stock → 471,057 Class A Common Stock | Class B Common Stock | Ackerman John Director | -471,057 | — | — | 471,057 | low |
| Mar 28, 2026 | Other Option exercise · Class B Common Stock → 1,413,939 Class A Common Stock | Class B Common Stock | Ackerman John Director | -1,413,939 | — | — | 1,413,939 | low |
| Mar 28, 2026 | Other Option exercise | Class A Common Stock | Ackerman John Director | +471,057 | — | — | 816,180 | low |
| Mar 28, 2026 | Other Option exercise | Class A Common Stock | Ackerman John Director | +1,413,939 | — | — | 2,449,867 | low |
| Mar 28, 2026 | Other Option exercise · Class B Common Stock → 1,298,826 Class A Common Stock | Class B Common Stock | Burke Fred Executive | -1,298,826 | — | — | 1,298,825 | low |
| Mar 28, 2026 | Other Option exercise | Class A Common Stock | Burke Fred Executive | +1,298,826 | — | — | 2,139,239 | low |
| Mar 20, 2026 | Sell | Class A Common Stock | Morris David K Executive | -187,855 | $29.68 | $5.58M | 254,472 | medium |
| Mar 20, 2026 | Sell | Class A Common Stock | Pharmacy Investors, LLC | -827,636 | $29.68 | $24.57M | 1,035,928 | high |
| Mar 20, 2026 | Sell | Class A Common Stock | Burke Fred Executive | -671,432 | $29.68 | $19.93M | 840,413 | high |
| Mar 20, 2026 | Sell | Class A Common Stock | Salentine Thomas J Jr Director | -3,570,677 | $29.68 | $105.99M | 4,469,316 | high |
| Mar 20, 2026 | Sell | Class A Common Stock | Bindley Capital Partners I, LLC 10% owner | -3,570,677 | $29.68 | $105.99M | 4,469,316 | high |
| Mar 20, 2026 | Sell | Class A Common Stock | Ackerman John Director | -275,728 | $29.68 | $8.18M | 345,123 | medium |
| Mar 20, 2026 | Sell | Class A Common Stock | Ackerman John Director | -827,636 | $29.68 | $24.57M | 1,035,928 | high |
| Mar 20, 2026 | Sell | Class A Common Stock | BINDLEY WILLIAM E Director | -3,570,677 | $29.68 | $105.99M | 4,469,316 | high |
| Mar 20, 2026 | Sell | Class A Common Stock | Forbes Kendall Executive | -346,672 | $29.68 | $10.29M | 453,256 | medium |
| Mar 20, 2026 | Sell | Class A Common Stock | Cardinal Equity Fund, L.P. | -275,728 | $29.68 | $8.18M | 345,123 | medium |
| Mar 1, 2026 | Other Grant / award | Class A Common Stock | Morris David K Executive | +8,952 | $0.00 | $0 | 442,327 | low |
| Mar 1, 2026 | Other Grant / award | Class A Common Stock | Forbes Kendall Executive | +8,952 | $0.00 | $0 | 799,928 | low |